Pharmacy & Therapeutics- July 2008 - (Page bb1) See the accompanying advertisement in this publication to learn more about CIMZIA. CIMZIA is indicated for reducing signs and symptoms of Crohn’s disease and maintaining clinical response in adult patients with moderately to severely active disease who have had an inadequate response to conventional therapy. Please see Warnings and Precautions on the back of this flap, Brief Summary of full Prescribing Information adjacent to the CIMZIA advertisement inside this publication, and visit www.cimzia.com for full Prescribing Information. http://www.cimzia.com http://www.cimzia.com
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.